Process Development

Process Development
Product Description

PharmaResources provides comprehensive process development solutions from route scouting to commercial manufacturing. Our experienced R&D team supports retrosynthetic analysis, novel route design, reaction optimization, and process scale-up. Through systematic studies of reaction parameters, catalyst selection, solvent systems, and process conditions, we improve yield, enhance safety, reduce waste, and shorten production cycles. Our capabilities also include technology transfer, analytical method development, process documentation, and GMP manufacturing support to ensure smooth transition from laboratory research to commercial production.

PharmaResources (Kaiyuan) Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Laboratory Services

PharmaResources (Kaiyuan) Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Contract Research Organisation
Laboratory Services

More Products from PharmaResources (Kaiyuan) Co., Ltd. (9)

  • Ticagrelor

    Product Ticagrelor

    CAS NO.: 274693-27-5 USDMF CEP GMP
  • Ticagrelor Intermediates

    Product Ticagrelor Intermediates

    CAS NO.: 376608-65-0 CAS NO.: 145783-15-9 CAS NO.: 1156491-10-9 CAS NO.: 376608-71-8 CAS NO.: 145783-14-8 CAS NO.: 376608-74-1 CAS NO.: 155899-66-4
  • AI & Computational Drug Design

    Product AI & Computational Drug Design

    PharmaResources integrates artificial intelligence, computational chemistry, and expert medicinal chemistry knowledge to accelerate drug discovery and optimization. Our AI-driven platform supports molecule generation, structure-based and ligand-based design, virtual screening, ADMET prediction, and propert...
  • Drug Discovery and Screening

    Product Drug Discovery and Screening

    PharmaResources provides integrated drug discovery solutions combining medicinal chemistry, chemical biology, and advanced screening technologies. Our capabilities cover target validation, hit identification, lead optimization, SAR-based design, ADME/PK evaluation, and candidate optimization. With expertis...
  • Flow Chemistry (CDMO)

    Product Flow Chemistry (CDMO)

    PharmaResources provides advanced flow chemistry solutions to improve reaction safety, efficiency, and scalability in pharmaceutical development and manufacturing. Our capabilities cover continuous flow reactions, photochemistry, metal-mediated reactions, high-pressure reactions, and challenging transforma...
  • High Potency API

    Product High Potency API

    PharmaResources provides integrated HPAPI development and manufacturing capabilities, supporting projects from early research to clinical and commercial supply. Our high-containment facilities are designed for the safe handling of highly potent compounds, with capabilities covering route scouting, process ...
  • Huperzine-A Intermediates

    Product Huperzine-A Intermediates

    CAS NO.: 185741-44-0 CAS NO.: 130518-34-2
  • L-Carnitine

    Product L-Carnitine

    CAS NO.:541-15-1 USDMF CEP
  • Peramivir trihydrate

    Product Peramivir trihydrate

    CAS NO.: 1041434-82-5 DMF

PharmaResources (Kaiyuan) Co., Ltd. resources (4)

  • News PharmaResources Marketing-CADD Service

    Our Computer-aided Drug Design (CADD) team has standardized procedures and highly-skilled scientists for solving complex problems related to discovery. The CADD team routinely supports discovery projects starting from target identification to lead optimization. We can provide virtual screening, scaffold hopping and de-novo molecule design. We have a wide range of tools available for compound optimization. Also, we have proven expertise in collaborative small molecule, PROTAC and peptide drug discovery projects.
  • Brochure PharmaResources

    PharmaResources is a fast growing CRO/CDMO company based in China, which is a one-stop service provider of small molecules for new drug discovery and manufacturing. Currently we have around 1000 scientists, focusing on medicinal chemistry, process development, DMPK, pharmaceutical researching and GMP manufacturing.